The National Stem Cell Translational Resource Bank (NSCTRB) relies on Tongji University, and joint established by the Shanghai East Hospital (stem cell resources of clinical grade ) and the School of Life Sciences and Technology (stem cell resources of research grade). It has invested more than 150 million yuan.

NSCTRB contains various stem cell resources of both clinical and research grade, especially a sub-bank composed with HLA high-frequency iPSC lines in which the HLA types could match more than 60% of the Chinese population. It can not only provide services to stem cell clinical researches and translation applications, but also provide effective resources for scientific research to the Universities, research institutes, companies, etc. The bank has complete standards, specifications and relevant management systems, and has more than 200 perfessonals in the field of stem cells.

In order to comply with the major strategy tasks of National Population Health and the requirements of economic and social development, the bank aims to bulid a National Stem Cell Translational Resource Bank with full range of resources and abundant resource reserves. Moreover, leading the healthy development of stem cell industry through integrating bio-information resources and formulating industry standards, which makes stem cell resources well-documented and traceable.

In summary, NSCTRB provide important support for the development of stem cell basic research, clinical translation, new drug development and other fields in China, which finally achieve a new situation of "Constructing Together, Benefiting Together and Winning Together”in the Chinese stem cell industry.